MALIGNANT CRANIAL NERVE NEOPLASM

This adverse event was reported 26 times

These drugs are most commonly taken by patients reporting MALIGNANT CRANIAL NERVE NEOPLASM:

# Drug Count
0 CANNABIDIOL 18
1 DINUTUXIMAB 18
2 FAMOTIDINE 18
3 GABAPENTIN 18
4 LORAZEPAM 18
5 LORLATINIB 17
6 TEMOZOLOMIDE 17
7 DEXAMETHASONE SODIUM PHOSPHATE 16
8 METHADONE 16
9 METHADONE HYDROCHLORIDE 16
See all common drugs associated with MALIGNANT CRANIAL NERVE NEOPLASM

MALIGNANT CRANIAL NERVE NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DINUTUXIMAB 18 0.0210
1 LORLATINIB 17 0.0023
2 DEXAMETHASONE SODIUM PHOSPHATE 16 0.0015
3 METHADONE HYDROCHLORIDE 16 0.0015
4 TEMOZOLOMIDE 17 0.0008
5 CANNABIDIOL 18 0.0007
6 IRINOTECAN HYDROCHLORIDE 7 0.0005
7 DACTINOMYCIN 1 0.0005
8 METHADONE 16 0.0004
9 HYDROMORPHONE HYDROCHLORIDE 14 0.0002
See all drugs enriched for association with MALIGNANT CRANIAL NERVE NEOPLASM

MALIGNANT CRANIAL NERVE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Glycolipid Disialoganglioside-directed Antibody [EPC] 18 0.0166
1 Actinomycin [EPC] 1 0.0005
2 Histamine-2 Receptor Antagonist [EPC] 18 0.0001
3 Alkylating Drug [EPC] 20 0.0001
4 Provitamin D2 Compound [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 17 0.0000
6 Benzodiazepine [EPC] 18 0.0000
7 Androgen Receptor Inhibitor [EPC] 1 0.0000
8 Platinum-based Drug [EPC] 2 0.0000
9 Calcium [EPC] 1 0.0000
See all drug classes enriched for association with MALIGNANT CRANIAL NERVE NEOPLASM